| Dr David Clark Hatch, MD | |
|
601 W Leota St, North Platte, NE 69101-6525 | |
| (308) 647-6444 | |
| (308) 647-6433 |
| Full Name | Dr David Clark Hatch |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 28 Years |
| Location | 601 W Leota St, North Platte, Nebraska |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1407871908 | NPI | - | NPPES |
| 7705720 | Medicaid | SD | |
| 300133488 | Other | MEDICARE RAILROAD | |
| 35792 | Other | NE | BLUE CROSS / BLUE SHIELDS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | 21277 (Nebraska) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Great Plains Health | North platte, NE | Hospital |
| Community Hospital | Mccook, NE | Hospital |
| Perkins County Health Services | Grant, NE | Hospital |
| Jennie M Melham Memorial Medical Center | Broken bow, NE | Hospital |
| Cherry County Hospital | Valentine, NE | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Radiology Services, P.c. | 5395710800 | 5 |
News Archive
A study based on more than 87,000 women and 47,000 men in the Nurses' Health Study and the Health Professionals Follow-up Study, looks at whether there is a link between colon cancer and alcohol, and if so at what level of consumption, and the importance of a family history of the disease. A total of 1,801 cases of colon cancer were diagnosed during follow-up from 1980 onwards.
A major international trial has shown a commonly used chemotherapy drug is as effective at helping prevent pancreatic cancer returning after surgery as the more expensive standard chemotherapy treatment, reveals a study published in the Journal of the American Medical Association today (Wednesday).
TessArae, LLC, a privately held company, and Affymetrix Inc., (NASDAQ:AFFX) today announced that the Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) to TessArae for its TessArray® Resequencing Influenza A Microarray Detection Panel for the Detection of the 2009 H1N1 Influenza A Virus (TessArray RM-Flu test) for the duration of the declaration of emergency unless revoked earlier. The declaration of emergency will expire on April 26, 2010, unless terminated earlier or renewed.
A novel compound has shown promise in preclinical studies as a treatment for acute myeloid leukemia, more than doubling median days of survival even in a drug-resistant form of the disease.
St. Jude Medical, Inc., a global medical device company, today completed the previously announced acquisition of LightLab Imaging, Inc. for approximately $90 million in cash.
› Verified 4 days ago
| Entity Name | Radiology Services, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1851476436 PECOS PAC ID: 5395710800 Enrollment ID: O20040828000148 |
News Archive
A study based on more than 87,000 women and 47,000 men in the Nurses' Health Study and the Health Professionals Follow-up Study, looks at whether there is a link between colon cancer and alcohol, and if so at what level of consumption, and the importance of a family history of the disease. A total of 1,801 cases of colon cancer were diagnosed during follow-up from 1980 onwards.
A major international trial has shown a commonly used chemotherapy drug is as effective at helping prevent pancreatic cancer returning after surgery as the more expensive standard chemotherapy treatment, reveals a study published in the Journal of the American Medical Association today (Wednesday).
TessArae, LLC, a privately held company, and Affymetrix Inc., (NASDAQ:AFFX) today announced that the Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) to TessArae for its TessArray® Resequencing Influenza A Microarray Detection Panel for the Detection of the 2009 H1N1 Influenza A Virus (TessArray RM-Flu test) for the duration of the declaration of emergency unless revoked earlier. The declaration of emergency will expire on April 26, 2010, unless terminated earlier or renewed.
A novel compound has shown promise in preclinical studies as a treatment for acute myeloid leukemia, more than doubling median days of survival even in a drug-resistant form of the disease.
St. Jude Medical, Inc., a global medical device company, today completed the previously announced acquisition of LightLab Imaging, Inc. for approximately $90 million in cash.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr David Clark Hatch, MD Po Box 362, North Platte, NE 69103-0362 Ph: (308) 647-6444 | Dr David Clark Hatch, MD 601 W Leota St, North Platte, NE 69101-6525 Ph: (308) 647-6444 |
News Archive
A study based on more than 87,000 women and 47,000 men in the Nurses' Health Study and the Health Professionals Follow-up Study, looks at whether there is a link between colon cancer and alcohol, and if so at what level of consumption, and the importance of a family history of the disease. A total of 1,801 cases of colon cancer were diagnosed during follow-up from 1980 onwards.
A major international trial has shown a commonly used chemotherapy drug is as effective at helping prevent pancreatic cancer returning after surgery as the more expensive standard chemotherapy treatment, reveals a study published in the Journal of the American Medical Association today (Wednesday).
TessArae, LLC, a privately held company, and Affymetrix Inc., (NASDAQ:AFFX) today announced that the Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) to TessArae for its TessArray® Resequencing Influenza A Microarray Detection Panel for the Detection of the 2009 H1N1 Influenza A Virus (TessArray RM-Flu test) for the duration of the declaration of emergency unless revoked earlier. The declaration of emergency will expire on April 26, 2010, unless terminated earlier or renewed.
A novel compound has shown promise in preclinical studies as a treatment for acute myeloid leukemia, more than doubling median days of survival even in a drug-resistant form of the disease.
St. Jude Medical, Inc., a global medical device company, today completed the previously announced acquisition of LightLab Imaging, Inc. for approximately $90 million in cash.
› Verified 4 days ago
Dr. Ladd Daniel Lake, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 601 W Leota St, North Platte, NE 69101 Phone: 308-696-7491 Fax: 308-696-7432 | |
Dr. Todd E Hlavaty, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 601 W Leota St, North Platte, NE 69101 Phone: 308-696-7741 | |
Jed T Hollingsworth, D.O. Radiology Medicare: Accepting Medicare Assignments Practice Location: 601 W Leota St, North Platte, NE 69101 Phone: 308-568-7470 Fax: 308-535-3441 |